Skip to content

Viatris VTRS Inventories

Inventories at other companies

Pfizer logo
PfizerPFE
$2.46B-11.9%
McKesson logo
McKessonMCK
$24.21B+5.2%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$143.47M+4.4%
Cencora logo
CencoraCOR
$20.01B+5.5%
AMP
Amphastar PharmaceuticalsAMPH
$170.19M-8.2%
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
$8.07M+12.1%

Other financials

Income statement

See full
Revenue$3.5B+8.1%
Gross profit$1.2B-0.3%
Operating income-$79.7M+97.2%
Net income$176.4M+106%
EPS (diluted)$0.15+106%

Balance sheet

See full
Cash & equivalents$1.8B+139%
Total debt$14.6B+1.0%
Total equity$14.7B-6.3%
Total assets$36.8B-4.3%

Cash flow

See full
Operating cash flow$388.3M-27.5%
CapEx$39.9M-6.3%
Free cash flow$348.4M-29.3%

Valuation

See full
Market cap$20.8B+92.8%
Enterprise value$33.61B+34.5%
P/S1.4×+0.7×

Profitability

See full
Gross margin34.4%-2.5pp
Operating margin1%
Net margin-2%-1.0pp
FCF margin12.3%-1.0pp

Returns & leverage

See full
Return on equity-2%-0.9pp
Debt / equity+0.1×
Current ratio1.6×-0.1×

Where this comes from

Reported directly by Viatris in its filing.

Tagged under the XBRL concept us-gaap:InventoryNet.

The official record: Viatris’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viatris's inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viatris's inventories?
Viatris (VTRS) reported inventories of $3.93B in Q1 2026.
How has Viatris's inventories changed year-over-year?
Viatris's inventories decreased by 4.1% year-over-year, from $4.1B to $3.93B.
What is the long-term trend for Viatris's inventories?
Over 4 years (2021 to 2025), Viatris's inventories has grown at a -1.5% compound annual growth rate (CAGR), from $17.49B to $16.47B.
What does inventories mean?
Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.